This course discusses the necessary considerations for optometrists while managing patients who may be pregnant or breastfeeding. The treatment of acute and chronic ocular conditions using oral and topical medications will be highlighted, with a focus on risk-benefit evaluation. The role of the FDA in evaluating the safety and efficacy of medications in pregnant and nursing individuals will be evaluated. Additionally, maximizing the utility of available key resources for prescribers will be presented.

Course Code:



Jessica Steen, O.D.



AOA Expiration Date:


Related News

What defines the value of care we provide?

Health and vision plans have not adapted and grown with the care we deliver but hold back optometry’s momentum.

How to speak the universal language of care

How to create a bilingual and culturally sensitive practice, why it matters to patients and how it can set you apart from the competition.

Doctors of optometry challenge reasoning behind proposed Eyeglass Rule changes at FTC workshop

The recent workshop heard testimony from various stakeholders on the potential impact that proposed changes to the Eyeglass Rule might have on consumer choice and the burden on the practices of doctors of optometry and ophthalmology, which are already understaffed and saddled with other federal regulation. The Federal Trade Commission will use the feedback to determine whether to go forward with its recommendations.